Skip to main content
Fueled by foundational teaching and innovative research, the Disease and Therapeutic Response Modeling Program equips young scientists with diverse experiences in the design, application and interpretation of quantitative approaches that drive the evolution of medical therapies. The Annual Indiana CTSI Disease and Therapeutic Response Modeling Symposium is made possible by our donors, whose incredible generosity and support make this event accessible to all.

13th Annual Indiana CTSI Disease and Therapeutic Response Modeling Symposium

13th Annual Indiana CTSI Disease and Therapeutic Response Modeling Symposium

The 13th Annual Indiana CTSI Disease and Therapeutic Response Modeling Symposium, will take place Tuesday, February 27 to Thursday, February 29, 2024, at Hine Hall in Indianapolis, IN on the vibrant IUPUI campus. This will be a collaboration between the Maternal and Pediatric Precision in Therapeutics (MPRINT) Hub and the Indiana CTSI Disease and Therapeutic Modeling & Simulation Program.


The 13th Annual Indiana CTSI Disease and Therapeutic Response Modeling Symposium is made possible by our donors, whose incredible generosity and support make this event accessible to all:

 Gilead Logo  Eli Lilly Logo Metrum Research Group Logo 
 ISOP Logo    abbvie Logo

 

In-person registration is limited to 70 and will be on a first come, first serve basis. A virtual option will also be provided. Please register by February 16, 2024.

Register

Draft Agenda

The 13th Annual Indiana CTSI Disease and Therapeutic Response Modeling Symposium, will take place Tuesday, February 27 to Thursday, February 29, 2024, at Hine Hall in Indianapolis, IN

Anticipated Presenters

Rena Byrne, PhD, Senior Scientist, Metrum Research Group

Sam Callisto, PhD, Metrum Research Group

Mary Choules, PharmD, PhD, Associate Director, New Technologies, Astellas Pharma Global, Inc

Mathangi Gopalakrishnan, MPharm, PhD, FCP Assistant Professor Center for Translational Medicine, University of Maryland School of Pharmacy

Emma Hughes, PhD Gilead Sciences

Mutaz Jaber, PharmD, PhD, Gilead Sciences

Ryan Jarrett, PhD, Advisor, Global PK/PD & Pharmacometrics, Eli Lilly & Company

Lang Li, Ph, Professor and Chair Department of Biomedical Informatics, College of Medicine, The Ohio State University

Sven Mensing, PhD, Head of Pharmacometrics, Abbvie

Tomoyuki Mizuno, PhD,Associate Professor of Clinical Pharmacology & Toxicology, Cincinnati Children’s Hospital

Yuki Otani, MD, PhD, Advisor, Global PK/PD and Pharmacometrics, Eli Lilly & Company

Elimika Pfuma Fletcher, PharmD, PhD, Clinical Pharmacology Policy Lead, U.S. Food and Drug Administration

Sue Abdul-Rahman, PharmD, Chief Science Officer, Health Data Synthesis Institute

N. Jim Rhodes, PharmD, MSc, BCPS-AQ Infectious Disease, Associate Professor of Pharmacy Practice, Midwestern University, Pharmacometrics Center of Excellence, Midwestern University, Chicago College of Pharmacy

Stephan Schmidt, BPharm, PhD, FCP Professor & Director, Center for Pharmacometrics & Systems Pharmacology, University of Florida

Stacey Tannenbaum, PhD, Metrum Research Group

Jonathan Wagner, DO Director, Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children’s Mercy Hospital, Kansas City

Kash Yellepedi, PhD, RPh, DABCP, Associate Professor Division of Clinical Pharmacology, University of Utah

Cindy Yeung, PhD, MSc, Postdoctoral Research Fellow, The Hospital for Sick Children

Yifan Yu, BS, MS, Graduate Student, University of Buffalo

Songmao (Ben) Zheng, PhD, BS, Vice President of Clinical and Quantitative Pharmacology, Adagene

Autism Fellowship Research Training

REGISTER NOW

In-person registration is limited to 70 and will be on a first come, first serve basis. A virtual option will also be provided. Please register by February 16, 2024.

Registration Link